13F-HR filed by Logos Global Management LP
Logos Global Management LP filed this 13F-HR for the quarter ended 2023-12-31, filed 2024-02-14, with 53 holding rows worth $1,071,303,946.
- Accession
- 0001172661-24-001344
- Filer
- CIK 1792126
- Filed
- 2024-02-14
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q4 2023
A holdings report, 53 entries on the cover page, a total value of $1,071,303,946 stated on the cover page (in dollars after the unit check, H1), rows summing to $1,071,303,946 with VALUE read as dollars as filed, 13F file number 028-20025. The quarter's positions are built on this report. The resolved quarter.
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| CYTOKINETICS INC | 23282W605 | COM NEW | 1,625,000 | $135,671,250 | dollars as filed | |
| SAREPTA THERAPEUTICS INC | 803607100 | COM | 700,000 | $67,501,000 | dollars as filed | call |
| IDEAYA BIOSCIENCES INC COM | 45166A102 | Stock | 1,800,000 | $64,044,000 | dollars as filed | |
| APELLIS PHARMACEUTICALS INC | 03753U106 | COM | 1,000,000 | $59,860,000 | dollars as filed | call |
| APELLIS PHARMACEUTICALS INC | 03753U106 | COM | 950,000 | $56,867,000 | dollars as filed | |
| ARGENX SE SPONSORED ADR | 04016X101 | ADR | 145,000 | $55,162,350 | dollars as filed | |
| OLEMA PHARMACEUTICALS INC | 68062P106 | COM | 4,383,875 | $54,376,702 | dollars as filed | |
| IMMUNOVANT INC | 45258J102 | COM | 1,200,000 | $50,556,000 | dollars as filed | |
| STRUCTURE THERAPEUTICS INC COMP | 86366E106 | EQUITY | 1,070,058 | $43,615,564 | dollars as filed | |
| ROCKET PHARMACEUTICALS INC | 77313F106 | COM | 1,275,000 | $38,211,750 | dollars as filed | |
| RAYZEBIO INC | 75525N107 | COM | 568,173 | $35,323,315 | dollars as filed | |
| AMBRX BIOPHARMA INC | 641871108 | COM | 2,100,000 | $29,904,000 | dollars as filed | |
| KARUNA THERAPEUTICS INC | 48576A100 | COM | 90,000 | $28,485,900 | dollars as filed | |
| IMMUNOCORE HLDGS PLC ADS | 45258D105 | ADR | 400,000 | $27,328,000 | dollars as filed | |
| DYNE THERAPEUTICS INC COM | 26818M108 | Stock | 1,880,000 | $25,004,000 | dollars as filed | |
| ANNEXON INC | 03589W102 | COM | 4,950,000 | $22,473,000 | dollars as filed | |
| INHIBRX INC | 45720L107 | COM | 500,000 | $19,000,000 | dollars as filed | call |
| AKERO THERAPEUTICS INC | 00973Y108 | COM | 800,000 | $18,680,000 | dollars as filed | |
| OCULAR THERAPEUTIX INC | 67576A100 | COM | 4,000,000 | $17,840,000 | dollars as filed | |
| MORPHOSYS AG | 617760202 | ADR | 1,475,000 | $14,602,500 | dollars as filed | |
| DESIGN THERAPEUTICS INC | 25056L103 | COM | 5,032,501 | $13,336,128 | dollars as filed | |
| VIRIDIAN THERAPEUTICS INC | 92790C104 | COM | 600,000 | $13,068,000 | dollars as filed | |
| EDGEWISE THERAPEUTICS INC | 28036F105 | COM | 950,000 | $10,393,000 | dollars as filed | |
| REVOLUTION MEDICINES INC COM | 76155X100 | Stock | 350,000 | $10,038,000 | dollars as filed | |
| MORPHOSYS AG | 617760202 | ADR | 1,000,000 | $9,900,000 | dollars as filed | call |
| ACELYRIN INC | 00445A100 | COM | 1,250,000 | $9,325,000 | dollars as filed | |
| MOONLAKE IMMUNOTHERAPEUTICS CLASS A ORD | 61559X104 | Stock | 150,000 | $9,058,500 | dollars as filed | |
| ATYR PHARMA INC | 002120202 | COM NEW | 5,850,000 | $8,248,500 | dollars as filed | |
| IOVANCE BIOTHERAPEUTICS INC | 462260100 | COM | 1,000,000 | $8,130,000 | dollars as filed | call |
| FULCRUM THERAPEUTICS INC | 359616109 | COMMON STOCK | 1,200,000 | $8,100,000 | dollars as filed | |
| ALLAKOS INC | 01671P100 | COM | 2,900,000 | $7,917,000 | dollars as filed | |
| ZENTALIS PHARMACEUTICALS INC | 98943L107 | COMMON STOCK | 500,000 | $7,575,000 | dollars as filed | call |
| Tourmaline Bio Inc | 89157D105 | Common Stock | 284,372 | $7,444,859 | dollars as filed | |
| AVIDITY BIOSCIENCES INC COM | 05370A108 | Stock | 775,000 | $7,013,750 | dollars as filed | |
| SILENCE THERAPEUTICS PLC | 82686Q101 | ADS | 400,000 | $6,948,000 | dollars as filed | |
| XENON PHARMACEUTICALS INC COM | 98420N105 | Stock | 150,000 | $6,909,000 | dollars as filed | |
| NEUMORA THERAPEUTICS INC. | 640979100 | COM | 382,345 | $6,518,982 | dollars as filed | |
| ARCUS BIOSCIENCES INC | 03969F109 | COM | 325,000 | $6,207,500 | dollars as filed | |
| MORPHIC HLDG INC | 61775R105 | COM | 200,000 | $5,776,000 | dollars as filed | |
| Applied Therapeutics Inc | 03828A101 | Common Stock | 1,660,000 | $5,561,000 | dollars as filed | |
| Ventyx Biosciences Inc | 92332V107 | Common Stock | 2,000,000 | $4,940,000 | dollars as filed | |
| ICOSAVAX INC | 45114M109 | COM | 300,000 | $4,728,000 | dollars as filed | |
| REPARE THERAPEUTICS INC | 760273102 | COM | 600,000 | $4,380,000 | dollars as filed | |
| COMPASS PATHWAYS PLC | 20451W101 | SPONSORED ADS | 500,000 | $4,375,000 | dollars as filed | |
| ENLIVEN THERAPEUTICS INC COM | 29337E102 | Stock | 307,076 | $4,249,932 | dollars as filed | |
| ASTRIA THERAPEUTICS INC COM | 04635X102 | Stock | 544,960 | $4,185,293 | dollars as filed | |
| INHIBRX INC | 45720L107 | COM | 100,000 | $3,800,000 | dollars as filed | |
| SPYRE THERAPEUTICS INC | 00773J202 | COM NEW | 150,000 | $3,228,000 | dollars as filed | |
| KINIKSA PHARMACEUTICALS LTD | G5269C101 | COM CL A | 150,000 | $2,631,000 | dollars as filed | |
| DELCATH SYSTEMS INC | 24661P807 | COMMON STOCK | 300,000 | $1,248,000 | dollars as filed | |
| IO BIOTECH INC | 449778109 | COM | 493,827 | $928,395 | dollars as filed | |
| IMMUNIC INC | 4525EP101 | COM | 421,184 | $631,776 | dollars as filed | |
| NUVATION BIO INC | 67080N119 | WARR | 66,666 | $4,000 | dollars as filed |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0001172661-24-001344 | this filing | 2024-02-14 | acceptance time not in the bulk data set |